Back to DE D. E. Shaw & Co., Inc.

GILDGILD
Showing 8 of 30 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in GILEAD SCIENCES INC

Yes. D. E. Shaw holds 2,294,789 shares of GILD (Gilead Sciences), worth $289.9M, as of its Q2 2026 13F filing. It increased the position from 200,919 shares in Q1 2026. D. E. Shaw has held GILD since Q4 2021, across 19 quarterly 13F filings. GILD is 0.1% of D. E. Shaw's reported 13F portfolio.

Current Value

$289.9M

Current Shares

2.3M

Total Value Change

+$227.8M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+1042.2%
$289.9M0.1%$125.63
60
2026-Q1
Increased
200,919
+4.3%
$28M0.0%$137.68
30
2025-Q4
Decreased
192,705
-53.4%
$23.7M0.0%$120.57
0
2025-Q3
Decreased
413,762
-40.9%
$45.9M0.0%$108.32
0
2025-Q2
Increased
700,228
+54.3%
$77.6M0.1%$107.45
42
2025-Q1
Decreased
453,756
-55.2%
$50.8M0.0%$107.83
0
2024-Q4
Increased
1M
+36.6%
$93.5M0.1%$88.27
39
2024-Q3
Decreased
741,201
-77.8%
$62.1M0.1%$79.45
0

Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used